Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'percutaneous coronary intervention' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 83 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schobel, WA; Spyridopoulos, I; Hoffmeister, HM; Seipel, L
      Percutaneous coronary interventions using a new 5 french guiding catheter:Results of a prospective study

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    2. Simon, DI; Liu, CB; Ganz, P; Kirshenbaum, JM; Piana, RN; Rogers, C; Selwyn, AP; Popma, JJ
      A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    3. Dippel, EJ; Kereiakes, DJ; Tramuta, DA; Broderick, TM; Shimshak, TM; Roth, EM; Hattemer, CR; Runyon, JP; Whang, DD; Schneider, JF; Abbottsmith, CW
      Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: An algorithm for percutaneous management

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    4. Grantham, JA; Tiede, DJ; Holmes, DR
      Technical considerations when intervening with coronary device catheters in the vicinity of previously deployed stents

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    5. Hod, HH; Kleiman, NS; Sequeira, RF; Voipio-Pulkki, LM
      Issues in cardiac intervention for UA/NSTEMI

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    6. Lindahl, B
      Detection of myocardial damage - are the troponins the ultimate solution?

      SCANDINAVIAN CARDIOVASCULAR JOURNAL
    7. Gaster, AL; Slothuus, U; Larsen, J; Thayssen, P; Haghfelt, T
      Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention

      SCANDINAVIAN CARDIOVASCULAR JOURNAL
    8. Benenati, J; Shlansky-Goldberg, R; Meglin, A; Seidl, E
      Thrombolytic and antiplatelet therapy in peripheral vascular disease with use of reteplase and/or abciximab - The SCVIR Consultants' Conference; May 22, 2000; Orlando, FL

      JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
    9. Lucore, CL; Trask, RV; Mishkel, GJ; Rocha-Singh, KJ; Shelton, ME; Mikell, FL; Ligon, RW
      Impact of abciximab and coronary stenting on outcomes and costs of percutaneous coronary interventions in a community hospital

      CORONARY ARTERY DISEASE
    10. Kereiakes, DJ; Lorenz, T; Young, JJ; Kukielka, G; Mueller, MN; Nanniazzi-Alaimo, L; Phillips, DR
      Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    11. Matzdorff, AC; Kuhnel, G; Kemkes-Matthes, B; Voss, R
      Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid plateletfunction analyzer

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    12. Proimos, G
      Platelet aggregation inhibition with glycoprotein IIb-IIIa inhibitors

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    13. Lev, EI; Osende, JI; Richard, MF; Robbins, JA; Delfin, JA; Rodriguez, O; Sharma, SK; Jayasundera, T; Badimon, JJ; Marmur, JD
      Administration of abciximab to patients receiving tirofiban or eptifibatide: Effect on platelet function

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    14. Nicholson, NS; Abood, NA; Panzer-Knodle, SG; Frederick, LG; Page, JD; Salyers, AK; Suleymanov, OD; Szalony, JA; Taite, BB; Anders, RJ
      Orbofiban: An orally active GPIIB/IIIa platelet receptor antagonist

      MEDICINAL RESEARCH REVIEWS
    15. Fry, ETA
      Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: A combined role in coronary interventions?

      CLINICAL CARDIOLOGY
    16. Sugiura, T; Yamasaki, F; Hatada, K; Nakamura, S; Iwasaka, T
      Correlates of bundle-branch block in patients undergoing primary angioplasty for acute myocardial infarction

      CLINICAL CARDIOLOGY
    17. Haumer, M; Atteneder, M; Ahmadi, R; Schillinger, M; Minar, E
      Coadministration of low-dose urokinase and abciximab in thrombolysis for lower limb ischemia - A safety study

      THROMBOSIS RESEARCH
    18. Shihara, M; Tsutsui, H; Tsuchihashi, M; Shigematsu, H; Yamamoto, S; Koike, G; Kono, S; Takeshita, A
      Coronary revascularization in Japan - Part 1: Survey of facilities during 1997

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    19. Tsuchihashi, M; Tsutsui, H; Shihara, M; Shigematsu, H; Yamamoto, S; Koike, G; Kono, S; Takeshita, A
      Coronary revascularization in Japan - Part 2: Comparison of facilities between 1997 and 1999

      JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION
    20. Fintel, DJ
      From bench to bedside - GP IIb-IIIa inhibitors

      NEUROLOGY
    21. Sabatine, MS; Braunwald, E
      Will diabetes save the platelet blockers?

      CIRCULATION
    22. Costa, MA; Carere, RG; Lichtenstein, SV; Foley, DP; de Valk, V; Lindenboom, W; Roose, PCH; van Geldorp, TR; Macaya, C; Castanon, JL; Fernandez-Avilez, F; Gonzales, JH; Heyer, G; Unger, F; Serruys, PW
      Incidence, predictors, and significance of abnormal cardiac enzyme rise inpatients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS)

      CIRCULATION
    23. Dillon, WC; Hadian, D; Ritchie, ME
      Refractory no-reflow successfully treated with local infusion of high-doseadenosine and verapamil - A case report

      ANGIOLOGY
    24. Antoniucci, D; Valenti, R; Migliorini, A; Moschi, G; Bolognese, L; Cerisano, G; Buonamici, P; Santoro, GM
      Direct infarct artery stenting without predilation and no-reflow in patients with acute myocardial infarction

      AMERICAN HEART JOURNAL
    25. Schneiderman, J; Morag, B; Gerniak, A; Rimon, U; Varon, D; Seligsohn, U; Shotan, A; Adar, R
      Abciximab in carotid stenting for postsurgical carotid restenosis: Intermediate results

      JOURNAL OF ENDOVASCULAR THERAPY
    26. Sdringola, S; Assali, A; Ghani, M; Yepes, A; Rosales, O; Schroth, GW; Fujise, K; Anderson, HV; Smalling, RW
      Adenosine use during aortocoronary vein graft interventions reverses but does not prevent the slow-no reflow phenomenon

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    27. Lotan, C; Dong, SH
      The no-reflow phenomenon: A light at the end of the tunnel?

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    28. Abernethy, WB; Choo, JK; Oesterle, SN; Jang, IK
      Balloon deflection technique: A method to facilitate entry of a balloon catheter into a deployed stent

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    29. Mak, KH; Effron, MB; Moliterno, DJ
      Platelet glycoprotein IIb/IIIa receptor antagonists and their use in elderly patients

      DRUGS & AGING
    30. Hilleman, DE
      New approaches to the management of AMI: Fibrinolysis plus GP IIb/IIIa receptor blockade

      FORMULARY
    31. Mager, A; Sclarovsky, S; Herz, I; Adler, Y; Strasberg, B; Birnbaum, Y
      Value of the initial electrocardiogram in patients with inferior-wall acute myocardial infarction for prediction of multivessel coronary artery disease

      CORONARY ARTERY DISEASE
    32. Hirsch, H; Lazar, J; Marzo, KP; Steingart, RM
      Percutaneous revascularization for unstable angina in the elderly

      CORONARY ARTERY DISEASE
    33. Cannon, CP
      Bridging the gap with new strategies in acute ST elevation myocardial infarction: Bolus thrombolysis, glycoprotein IIb/IIIa inhibitors, combination therapy, percutaneous coronary intervention, and "facilitated" PCI

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    34. Mukherjee, D; Moliterno, DJ
      Applications of anti-platelet monitoring in catheterization laboratory

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    35. Kalra, A; Jang, IK
      Prevalence of early left ventricular thrombus after primary coronary intervention for acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    36. Tiede, DJ; Brady, PA; Garratt, KN; Holmes, DR
      Resolution of the "no-reflow" phenomenon with intracoronary administrationof adenosine

      JOURNAL OF INTERVENTIONAL CARDIOLOGY
    37. Humphries, KH; Rankin, JM; Carere, RG; Buller, CE; Kiely, FM; Spinelli, JJ
      Co-morbidity data in outcomes research - Are clinical data derived from administrative databases a reliable alternative to chart review?

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    38. Hoekstra, J
      Glycoprotein IIB/IIIA receptor inhibitor use in unstable angina/non-ST-segment elevation myocardial infarction: An appropriate-use model for the emergency department

      JOURNAL OF EMERGENCY MEDICINE
    39. Chew, DP; Moliterno, DJ
      A critical appraisal of platelet glycoprotein IIb/IIIa inhibition

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    40. Ikari, Y; Yee, KO; Schwartz, SM
      Role of alpha 5 beta 1 and alpha v beta 3 integrins on smooth muscle cell spreading and migration in fibrin gels

      THROMBOSIS AND HAEMOSTASIS
    41. Furman, MI; Krueger, LA; Frelinger, AL; Barnard, MR; Mascelli, MA; Nakada, MT; Michelson, AD
      GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood

      THROMBOSIS AND HAEMOSTASIS
    42. Ikari, Y; Yee, KO; Hatsukami, TS; Schwartz, SM
      Human carotid artery smooth muscle cells rarely express alpha v beta 3 integrin at sites of recent plaque rupture

      THROMBOSIS AND HAEMOSTASIS
    43. Mukherjee, D; Moliterno, DJ
      Monitoring antiplatelet therapy - What is the best method?

      CLINICAL PHARMACOKINETICS
    44. Lqbal, O; Walenga, JM; Lewis, BE; Bakhos, M
      Bleeding complications with glycoprotein llb/llla inhibitors

      DRUGS OF TODAY
    45. Silvestry, SC; Smith, PK
      Current status of cardiac surgery in the abciximab-treated patient

      ANNALS OF THORACIC SURGERY
    46. Ambrose, JA; Hawkey, M; Badimon, JJ; Coppola, J; Geagea, JP; Rentrop, KP; Domiguez, A; Duvvuri, S; Elmquist, T; Arias, J; Doss, R; Dangas, G
      In vivo demonstration of an antithrombin effect of Abciximab

      AMERICAN JOURNAL OF CARDIOLOGY
    47. Kereiakes, DJ; Runyon, JP; Broderick, TM; Shimshak, TM
      IIb's are not IIb's

      AMERICAN JOURNAL OF CARDIOLOGY
    48. Mukherjee, D; Moliterno, DJ
      Achieving tissue-level perfusion in the setting of acute myocardial infarction

      AMERICAN JOURNAL OF CARDIOLOGY
    49. Moliterno, DJ; Mukherjee, D
      Applications of monitoring platelet glycoprotein IIb/IIIa antagonism and low molecular weight heparins in cardiovascular medicine

      AMERICAN HEART JOURNAL
    50. Gimelli, G; Kalra, A; Sabatine, MS; Jang, IK
      Primary versus rescue percutaneous corollary intervention in patients withacute myocardial infarction

      ACTA CARDIOLOGICA
    51. Shaknovich, A; Forman, ST; Parikh, MA; Deutsch, E; Bergman, GW; McCaffrey, TA; Newman, GC; Tarazona, N; Sanborn, TA
      Novel distal occluder washout method for prevention of no-reflow during stenting of saphenous vein grafts

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    52. Heldman, AW; Brinker, JA
      Yes reflow

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    53. Oesterle, SN; Hayase, M; Baim, DS; Teirstein, PS; Ramee, SR; Whitlow, PL; Webb, J; Virmani, R
      An embolization containment device

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    54. Gao, W; Koh, TH
      Retrograde embolization during saphenous vein graft angioplasty

      CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
    55. Kleiman, NS; Tcheng, JE
      Safety issues surrounding use of platelet GP IIb/IIIa antagonists: reversibility and readministration

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    56. Teirstein, P
      Overview of glycoprotein IIb/IIIa clinical trials with abciximab and eptifibatide in acute coronary syndromes and percutaneous coronary intervention

      JOURNAL OF INVASIVE CARDIOLOGY
    57. Becker, RC
      New thrombolytic, anticoagulants, and platelet antagonists: The future of clinical practice

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    58. Matetzky, S; Novikov, M; Gruberg, L; Freimark, D; Feinberg, M; Elian, D; Novikov, I; Di Segni, E; Agranat, O; Har-Zahav, Y; Rabinowitz, B; Kaplinsky, E; Hod, H
      The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    59. Gassler, JP; Topol, EJ
      Reperfusion revisited: Beyond TIMI3 flow

      CLINICAL CARDIOLOGY
    60. Cohen, M; Ferguson, JJ; Harrington, RA
      Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: Applicability to the practice of medicine in the United States

      CLINICAL CARDIOLOGY
    61. Kleiman, NS
      A risk-benefit assessment of abciximab in angioplasty

      DRUG SAFETY
    62. Vorchheimer, DA; Badimon, JJ; Fuster, V
      Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    63. Goa, KL; Noble, S
      Eptifibatide - A review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention

      DRUGS
    64. Harder, S; Kirchmaier, CM; Krzywanek, HJ; Westrup, D; Bae, JW; Breddin, HK
      Pharmacokinetics and pharmacodynamic effects of a new antibody glycoprotein IIb/IIIa inhibitor (YM337) in healthy subjects

      CIRCULATION
    65. Despotis, GJ; Hogue, CW
      Pathophysiology, prevention, and treatment of bleeding after cardiac surgery: A primer for cardiologists and an update for the cardiothoracic team

      AMERICAN JOURNAL OF CARDIOLOGY
    66. Blankenship, JC
      Bleeding complications of glycoprotein IIb-IIIa receptor inhibitors

      AMERICAN HEART JOURNAL
    67. GULBA DC; HUBER K; MOLL S; DIETZ R
      PLATELET INHIBITION - NEW AGENTS, NEW STRATEGIES, NEW TRIALS

      FIBRINOLYSIS & PROTEOLYSIS
    68. LE KM
      UPDATE ON GLYCOPROTEIN IIB IIIA BLOCKADE IN ENDOVASCULAR INTERVENTIONS/

      Journal of interventional cardiology
    69. TSUNODA T; NAKAMURA M; WAKATSUKI T; NISHIDA T; ASAHARA T; ANZAI H; TOUMA H; MITSUO K; SOUMITSU Y; SAKATANI H; NAKAMURA S; DEGAWA T; YAMAGUCHI T
      THE PATTERN OF ALTERATION IN FLOW VELOCITY IN THE RECANALIZED ARTERY IS RELATED TO LEFT-VENTRICULAR RECOVERY IN PATIENTS WITH ACUTE INFARCTION AND SUCCESSFUL DIRECT BALLOON ANGIOPLASTY

      Journal of the American College of Cardiology
    70. TCHENG JE
      PERSPECTIVES ON THE FUTURE OF PLATELET GLYCOPROTEIN IIB IIIA BLOCKADETHERAPY/

      Texas Heart Institute journal
    71. CHRONOS N; VAHANIAN A; BETRIU A; EMANUELSSON H; GOLDBERG S; GULBA D; VANHOUT BA
      USE OF ABCIXIMAB IN INTERVENTIONAL CARDIOLOGY

      European heart journal
    72. Fischell, TA; Carter, AJ; Foster, MT; Hempsall, K; DeVries, J; Kim, DH; Kloostra, A
      Reversal of "no reflow" during vein graft stenting using high velocity boluses of intracoronary adenosine

      CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS
    73. MAK KH; TAN ATH; CHAN C; KOH TH; TOPOL EJ
      THE CLINICAL IMPACT OF PLATELET GLYCOPROTEIN IIB IIIA RECEPTOR BLOCKADE IN CARDIOVASCULAR MEDICINE/

      Japanese Circulation Journal
    74. Madan, M; Berkowitz, SD; Tcheng, JE
      Glycoprotein IIb/IIIa integrin blockade

      CIRCULATION
    75. HARRINGTON RA; KLEIMAN NS; GRANGER CB; OHMAN EM; BERKOWITZ SD
      RELATION BETWEEN INHIBITION OF PLATELET-AGGREGATION AND CLINICAL OUTCOMES

      The American heart journal
    76. CHRONOS N; VAHANIAN A; BETRIU A; EMANUELSSON H; GOLDBERG S; GULBA D; VANHOUT BA
      USE OF ABCIXIMAB IN INTERVENTIONAL CARDIOLOGY

      The American heart journal
    77. TCHENG JE
      PLATELET GLYCOPROTEIN IIB IIIA INTEGRIN BLOCKADE - RECENT CLINICAL-TRIALS IN INTERVENTIONAL CARDIOLOGY/

      Thrombosis and haemostasis
    78. GEORGE BS
      THEORETICAL AND CLINICAL ASPECTS OF SLOW FLOW AND NO-REFLOW PHENOMENON

      The Journal of invasive cardiology
    79. KAPLAN BM; BENZULY KH; KINN JW; BOWERS TR; TILLI FV; GRINES CL; ONEILL WW; SAFIAN RD
      TREATMENT OF NO-REFLOW IN DEGENERATED SAPHENOUS-VEIN GRAFT INTERVENTIONS - COMPARISON OF INTRACORONARY VERAPAMIL AND NITROGLYCERIN

      Catheterization and cardiovascular diagnosis
    80. SHERMAN JR; ANWAR A; BRET JR; SCHREIBFEDER MM
      DISTAL VESSEL PULLBACK ANGIOGRAPHY AND PRESSURE-GRADIENT MEASUREMENT - AN INNOVATIVE DIAGNOSTIC-APPROACH TO EVALUATE THE NO-REFLOW PHENOMENON

      Catheterization and cardiovascular diagnosis
    81. BAIM DS; CARROZZA JP
      UNDERSTANDING THE NO-REFLOW PROBLEM

      Catheterization and cardiovascular diagnosis
    82. TCHENG JE
      GLYCOPROTEIN-IIB IIIA RECEPTOR INHIBITORS - PUTTING THE EPIC, IMPACT-II, RESTORE, AND EPILOG TRIALS INTO PERSPECTIVE/

      The American journal of cardiology
    83. AJLUNI SC; JONES D; ZIDAR F; PUCHROWICZ S; MARGULIS A; ONEILL WW; GRINES CL
      PROLONGED UROKINASE INFUSION FOR CHRONIC TOTAL NATIVE CORONARY OCCLUSIONS - CLINICAL, ANGIOGRAPHIC, AND TREATMENT OBSERVATIONS

      Catheterization and cardiovascular diagnosis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 09:49:52